Literature DB >> 33296617

TRPM3 expression and control of glutamate release from primary vagal afferent neurons.

Forrest J Ragozzino1, Rachel A Arnold1, Axel J Fenwick1, Timothy P Riley1, Jonathan E M Lindberg1, BreeAnne Peterson1, James H Peters1.   

Abstract

Vagal afferent fibers contact neurons in the nucleus of the solitary tract (NTS) and release glutamate via three distinct release pathways: synchronous, asynchronous, and spontaneous. The presence of TRPV1 in vagal afferents is predictive of activity-dependent asynchronous glutamate release along with temperature-sensitive spontaneous vesicle fusion. However, pharmacological blockade or genetic deletion of TRPV1 does not eliminate the asynchronous profile and only attenuates the temperature-dependent spontaneous release at high temperatures (>40°C), indicating additional temperature-sensitive calcium conductance(s) contributing to these release pathways. The transient receptor potential cation channel melastatin subtype 3 (TRPM3) is a calcium-selective channel that functions as a thermosensor (30-37°C) in somatic primary afferent neurons. We predict that TRPM3 is expressed in vagal afferent neurons and contributes to asynchronous and spontaneous glutamate release pathways. We investigated these hypotheses via measurements on cultured nodose neurons and in brainstem slice preparations containing vagal afferent to NTS synaptic contacts. We found histological and genetic evidence that TRPM3 is highly expressed in vagal afferent neurons. The TRPM3-selective agonist, pregnenolone sulfate, rapidly and reversibly activated the majority (∼70%) of nodose neurons; most of which also contained TRPV1. We confirmed the role of TRPM3 with pharmacological blockade and genetic deletion. In the brain, TRPM3 signaling strongly controlled both basal and temperature-driven spontaneous glutamate release. Surprisingly, genetic deletion of TRPM3 did not alter synchronous or asynchronous glutamate release. These results provide convergent evidence that vagal afferents express functional TRPM3 that serves as an additional temperature-sensitive calcium conductance involved in controlling spontaneous glutamate release onto neurons in the NTS.NEW & NOTEWORTHY Vagal afferent signaling coordinates autonomic reflex function and informs associated behaviors. Thermosensitive transient receptor potential (TRP) channels detect temperature and nociceptive stimuli in somatosensory afferent neurons, however their role in vagal signaling remains less well understood. We report that the TRPM3 ion channel provides a major thermosensitive point of control over vagal signaling and synaptic transmission. We conclude that TRPM3 translates physiological changes in temperature to neurophysiological outputs and can serve as a cellular integrator in vagal afferent signaling.

Entities:  

Keywords:  NTS; nodose; pregnenolone sulfate; quantal; temperature

Mesh:

Substances:

Year:  2020        PMID: 33296617      PMCID: PMC8087376          DOI: 10.1152/jn.00229.2020

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  47 in total

Review 1.  Presynaptic origins of distinct modes of neurotransmitter release.

Authors:  Natali L Chanaday; Ege T Kavalali
Journal:  Curr Opin Neurobiol       Date:  2018-03-26       Impact factor: 6.627

2.  Drosophila glial glutamate transporter Eaat1 is regulated by fringe-mediated notch signaling and is essential for larval locomotion.

Authors:  Stephanie M Stacey; Nara I Muraro; Emilie Peco; Alain Labbé; Graham B Thomas; Richard A Baines; Donald J van Meyel
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

3.  TRPM3 is a nociceptor channel involved in the detection of noxious heat.

Authors:  Joris Vriens; Grzegorz Owsianik; Thomas Hofmann; Stephan E Philipp; Julia Stab; Xiaodi Chen; Melissa Benoit; Fenqin Xue; Annelies Janssens; Sara Kerselaers; Johannes Oberwinkler; Rudi Vennekens; Thomas Gudermann; Bernd Nilius; Thomas Voets
Journal:  Neuron       Date:  2011-05-12       Impact factor: 17.173

Review 4.  Channeling satiation: a primer on the role of TRP channels in the control of glutamate release from vagal afferent neurons.

Authors:  Shaw-wen Wu; Axel J Fenwick; James H Peters
Journal:  Physiol Behav       Date:  2014-10-05

Review 5.  Transient receptor potential TRPM3 channels: Pharmacology, signaling, and biological functions.

Authors:  Gerald Thiel; Sandra Rubil; Andrea Lesch; Lisbeth A Guethlein; Oliver G Rössler
Journal:  Pharmacol Res       Date:  2017-07-16       Impact factor: 7.658

6.  Vanilloid receptors presynaptically modulate cranial visceral afferent synaptic transmission in nucleus tractus solitarius.

Authors:  Mark W Doyle; Timothy W Bailey; Young-Ho Jin; Michael C Andresen
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

7.  Genetic and pharmacological evidence for low-abundance TRPV3 expression in primary vagal afferent neurons.

Authors:  Shaw-Wen Wu; Jonathan E M Lindberg; James H Peters
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-02-03       Impact factor: 3.619

8.  TRPV1 marks synaptic segregation of multiple convergent afferents at the rat medial solitary tract nucleus.

Authors:  James H Peters; Stuart J McDougall; Jessica A Fawley; Michael C Andresen
Journal:  PLoS One       Date:  2011-09-20       Impact factor: 3.240

9.  Temperature differentially facilitates spontaneous but not evoked glutamate release from cranial visceral primary afferents.

Authors:  Jessica A Fawley; Mackenzie E Hofmann; Tally M Largent-Milnes; Michael C Andresen
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

Review 10.  Pregnenolone sulfate: from steroid metabolite to TRP channel ligand.

Authors:  Christian Harteneck
Journal:  Molecules       Date:  2013-09-27       Impact factor: 4.411

View more
  3 in total

1.  The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability.

Authors:  Siyuan Zhao; Tibor Rohacs
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 3.493

Review 2.  TRPM3 in Brain (Patho)Physiology.

Authors:  Katharina Held; Balázs István Tóth
Journal:  Front Cell Dev Biol       Date:  2021-02-26

3.  Therapeutic potential of TRPM8 antagonists in prostate cancer.

Authors:  Marzia Di Donato; Carmine Ostacolo; Pia Giovannelli; Veronica Di Sarno; Isabel M Gomez Monterrey; Pietro Campiglia; Antimo Migliaccio; Alessia Bertamino; Gabriella Castoria
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.